SCHEMBL30891925

SCHEMBL30891925

CCOC(=O)Cn1c(=O)[nH]c2ccccc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.64
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
CYP1A2 P05177 1/20 0.60
KDM4E B2RXH2 5/20 0.54
RAB9A P51151 2/20 0.54
TSHR P16473 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.51
HSD17B10 Q99714 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
HPGD P15428 2/20 0.48
SAE1 Q9UBE0 1/20 0.48
UBA2 Q9UBT2 1/20 0.48
CHRM2 P08172 1/20 0.47
CHRM4 P08173 1/20 0.47
CHRM5 P08912 1/20 0.47
CHRM1 P11229 1/20 0.47
CHRM3 P20309 1/20 0.47
POLB P06746 1/20 0.47
LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9139429 1.00 ALDH1A1 (0.64) ALDH1A1MEN1KMT2ACYP1A2KDM4E
SCHEMBL13129781 0.86 KMT2A (0.57) ALDH1A1MEN1KMT2ACYP1A2KDM4E
SCHEMBL7231747 0.85 KDM4E (0.67) ALDH1A1MEN1KMT2ACYP1A2KDM4E
SCHEMBL5323858 0.84 CYP1A2 (0.51) ALDH1A1MEN1KMT2ACYP1A2KDM4E
SCHEMBL10830938 0.84 TNF (0.58) ALDH1A1MEN1KMT2ACYP1A2KDM4E
SCHEMBL10487972 0.83 KDM4E (0.62) ALDH1A1MEN1KMT2ACYP1A2KDM4E
SCHEMBL13332558 0.83 CYP1A2 (0.62) ALDH1A1MEN1KMT2ACYP1A2KDM4E
SCHEMBL23997319 0.82 LMNA (0.60) ALDH1A1MEN1KMT2ACYP1A2KDM4E
SCHEMBL30345078 0.82 LMNA (0.60) ALDH1A1MEN1KMT2ACYP1A2KDM4E
SCHEMBL3591401 0.82 MEN1 (0.55) ALDH1A1MEN1KMT2ACYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665729-A1 DDR1 AND DDR2 INHIBITORS HAVING A DIHYDROBENZIMIDAZOLONE CORE Redx Pharma Limited (GB) 2025-12-24 EP disclosed
EP-4665728-A1 DDR1 AND DDR2 INHIBITORS HAVING A DIHYDROBENZIMIDAZOLONE CORE Redx Pharma Limited (GB) 2025-12-24 EP disclosed
EP-4577543-A1 PYRIDO-PYRAZOLES AS INHIBITORS OF DDR'S FOR THE TREATMENT OF FIBROTIC DISORDERS AND CANCER Redx Pharma Limited (GB) 2025-07-02 EP disclosed
CN-119768403-A Pyridopyrazoles as DDR inhibitors for the treatment of fibrotic disorders and cancer 莱德克斯制药有限公司 2025-04-04 CN disclosed
WO-2024170907-A1 DDR1 AND DDR2 INHIBITORS HAVING A DIHYDROBENZIMIDAZOLONE CORE REDX PHARMA LIMITED (GB) 2024-08-22 WO disclosed
WO-2024170909-A1 DDR1 AND DDR2 INHIBITORS HAVING A DIHYDROBENZIMIDAZOLONE CORE REDX PHARMA LIMITED (GB) 2024-08-22 WO disclosed